These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pro-apoptotic and immunomodulatory activity of a mycobacterial cell wall-DNA complex towards LNCaP prostate cancer cells. Reader S; Ménard S; Filion B; Filion MC; Phillips NC Prostate; 2001 Nov; 49(3):155-65. PubMed ID: 11746260 [TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis in human bladder cancer cells in vitro and in vivo caused by FTY720 treatment. Azuma H; Takahara S; Horie S; Muto S; Otsuki Y; Katsuoka Y J Urol; 2003 Jun; 169(6):2372-7. PubMed ID: 12771800 [TBL] [Abstract][Full Text] [Related]
4. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor. Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of cytokines on ovarian and endometrial carcinoma cells in vitro with special reference to induction of specific transcriptional regulators. Seppänen M; Henttinen T; Lin L; Punnonen J; Grénman S; Punnonen R; Vihko KK Oncol Res; 1998; 10(11-12):575-89. PubMed ID: 10367939 [TBL] [Abstract][Full Text] [Related]
6. Physician Education: The Erythropoietin Receptor and Signal Transduction. Yoshimura A; Arai K Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte colony-stimulating factor/granulocyte colony-stimulating factor receptor biological axis promotes survival and growth of bladder cancer cells. Chakraborty A; Guha S Urology; 2007 Jun; 69(6):1210-5. PubMed ID: 17572226 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall. Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro: alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction. Colquhoun A J Urol; 2009 Apr; 181(4):1885-93. PubMed ID: 19237174 [TBL] [Abstract][Full Text] [Related]
10. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma. Ripley D; Tang XM; Ma C; Chegini N Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966 [TBL] [Abstract][Full Text] [Related]
11. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells. Zou C; Liebert M; Zou C; Grossman HB; Lotan R J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527 [TBL] [Abstract][Full Text] [Related]
12. Effects of GM-CSF, IL-3, and GM-CSF/IL-3 fusion protein on apoptosis of human myeloid leukemic cell line Tf-1 induced by irradiation. Yang SR; Wen L; Lu YQ; Gong QY; Yu R; Yao MH Acta Pharmacol Sin; 2004 Jan; 25(1):68-75. PubMed ID: 14704125 [TBL] [Abstract][Full Text] [Related]
13. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2. Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342 [TBL] [Abstract][Full Text] [Related]
14. Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells. Kinoshita Y; Kono T; Yasumoto R; Kishimoto T; Wang CY; Haas GP; Nishisaka N J Immunother; 2001; 24(3):205-11. PubMed ID: 11394497 [TBL] [Abstract][Full Text] [Related]
15. Is interferon gamma one key of metastatic potential increase in human bladder carcinoma? Champelovier P; Simon A; Garrel C; Levacher G; Praloran V; Seigneurin D Clin Cancer Res; 2003 Oct; 9(12):4562-9. PubMed ID: 14555531 [TBL] [Abstract][Full Text] [Related]
16. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism. Du Z; Hou S J Urol; 2003 Nov; 170(5):2000-3. PubMed ID: 14532841 [TBL] [Abstract][Full Text] [Related]
17. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
18. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases. Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463 [TBL] [Abstract][Full Text] [Related]
19. Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells. Gopalan B; Litvak A; Sharma S; Mhashilkar AM; Chada S; Ramesh R Cancer Res; 2005 Apr; 65(8):3017-24. PubMed ID: 15833826 [TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]